877-202-0205     support@chemchart.com     @chemchart
        
Sign In    Register
   Reset Filters

Polycyclic organic compounds, Cyclopropanes, Three-membered rings, Experimental cancer drugs, Antineoplastic and immunomodulating drugs, Tetracyclic compounds

Categories

Antineoplastic drugs (1)
Cyclic compounds (1)
Cycloalkanes (1)
Halides (1)
Organofluorides (1)
Organohalides (1)
Pharmaceuticals (1)
Piperazines (1)
Six-membered rings (1)

Suppliers

Matrix Scientific (1)

Zosuquidar Trihydrochloride (167465-36-3)  
Zosuquidar (also LY-335979) is an experimental antineoplastic drug. In 2010, it was announced that a phase III trial for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome did not meet its primary endpoint and Eli Lilly discontinued its development. Zosquidir inhibits P-glycoproteins.
Related searches
Polycyclic organic compounds
Cyclopropanes
Three-membered rings
Experimental cancer drugs
Antineoplastic and immunomodulating drugs
Tetracyclic compounds